2002
DOI: 10.1111/j.1348-0421.2002.tb02766.x
|View full text |Cite
|
Sign up to set email alerts
|

Human Immunodeficiency Virus Type 1 Subtype C Exhibits Higher Transactivation Activity of Tat than Subtypes B and E

Abstract: Although human immunodeficiency virus type 1 (HIV‐1) subtypes C and E are expanding faster and seem to be of greater global significance than HIV‐1 subtype B, there is only little information about Tat activity of such non‐B subtypes. Here, we showed evidence that subtype C Tat exhibits higher transcriptional activity from the HIV‐1 long‐terminal repeat (LTR) in a human T‐cell line, compared with subtypes B and E. This higher activity of subtype C Tat was not due to the LTR, but to the Tat sequence variability… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

3
22
0

Year Published

2009
2009
2021
2021

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 32 publications
(25 citation statements)
references
References 65 publications
3
22
0
Order By: Relevance
“…Several publications previously demonstrated that an HIV-1 LTR containing three NF-B binding sites is a stronger viral promoter than the one that contains only two such sites (7,16,22,23). It was further proposed that the stronger viral promoter contributed significantly to the widespread global expansion of subtype C (5,24).…”
Section: Fig 2 Genetic Variation Within the C-b And Sp1iii Motifs Of mentioning
confidence: 99%
“…Several publications previously demonstrated that an HIV-1 LTR containing three NF-B binding sites is a stronger viral promoter than the one that contains only two such sites (7,16,22,23). It was further proposed that the stronger viral promoter contributed significantly to the widespread global expansion of subtype C (5,24).…”
Section: Fig 2 Genetic Variation Within the C-b And Sp1iii Motifs Of mentioning
confidence: 99%
“…These processes may be especially important in rapidly evolving genomes, such as those of RNA viruses, which feature high rates of mutation and recombination during replication (1,2). For example, the retrovirus human immunodeficiency virus-1 (HIV-1), 4 exhibits enormous sequence diversity, both within individual patients and among numerous subtypes and recombinants circulating throughout the world, which in many cases reduces viral fitness but can also promote its ability to adapt to different selective pressures applied by the host immune system and anti-retroviral drugs (2)(3)(4)(5)(6). In many cases, purifying selection purges mutations that reduce overall fitness; however, deleterious mutations at one residue may also be compensated for by mutations at other sites to maintain protein structure and function (7).…”
mentioning
confidence: 99%
“…Although Tat based vaccines would not be able to prevent an individual acquiring infection it could block viral replication and disease onset (post exposure vaccine) [11]. Invitro studies have shown subtype C Tat protein to have a higher transactivational potential than subtype B [5,6,13]. Development of such inhibitor/vaccines would have to take into consideration the variation of the Tat proteins not only in terms of their activity but also the variation in amino acid sequence analyzed in this study which could determine epitope presentation on MHC class I antigen for afferent immune response.…”
Section: Discussionmentioning
confidence: 99%
“…One such functional gene tat mediates an important role in transcription of the HIV-1 LTR [4]. Studies have also shown that there is a variation in levels of Tat transactivation among the different subtypes [5,6]. The tat mRNA is a multiply spliced mRNA and consists of two coding (1 and 2) and one noncoding exon.…”
Section: Introductionmentioning
confidence: 99%